// App-Quantinova.ai

263 : Epicatechin protects from doxorubicin induced cardiotoxicity without affecting its cytotoxic profile in breast cancer cells

Researchers

Presenter

  • Ohoud Y. Alshehri

Principal Investigators

  • Fahad A. Al-Abbasi

  • Hany M. El-Bassossy

  • Hossam M. Abdallah

  • Ahmed M. Al-Abd

Medical Centers

  • King Abdulaziz University, Jeddah, Saudi Arabia

  • Zagazig Univ, Zagazig, Egypt

  • Cairo University, Cairo, Egypt

  • National Research Center, Cairo, Egypt

Locations

  • Saudi Arabia

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myocardial ischemia

  • Cardiotoxicity

  • Breast cancer

  • Coronary Artery Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved